Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

XXeris Biopharma Holdings, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
X

Xeris Biopharma Holdings, Inc.

$8.73Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $92.1M. Net result −$31.1M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $92.1M. Running result $92.1M. Gvoke: $22.55M. Keveyis: $11.68M. Product Other: $0. Recorlev: $56.78M. Royalty Contract And Other Revenue: $1.1M.
  • Cost of revenue: −$12.51M. Running result $79.59M.
  • Gross profit: $79.59M. Running result $79.59M.
  • Operating costs: −$74.42M. Running result $5.17M.
  • Operating income: $5.17M. Running result $5.17M.
  • Other expense: −$36.27M. Running result −$31.1M.
  • Pre-tax loss: −$31.1M. Running result −$31.1M.
  • Income tax benefit: $0. Running result −$31.1M.
  • Net loss: −$31.1M. Running result −$31.1M.